Summary

The Europe gastrointestinal endoscopy market, is expected to reach USD 5,096,739.38 thousand by 2032 from USD 3,432,836.75 thousand in 2024, growing at a substantial CAGR of 5.2% in the forecast period of 2025 to 2032.
Market Segmentation:
Europe Gastrointestinal Endoscopy Market, Product (Gastrointestinal Endoscopes & Systems and Gastrointestinal Endotherapy), Application (Treatment and Diagnosis), Procedure Type (Colonoscopy, Gastroscopy, Duodenoscopy, Enteroscopy, Sigmoidoscopy and Others), Usability (Reusable and Disposable/ Single Use), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Laboratories, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country Germany, U.K., France, Russia, Italy, Spain, Turkey, Poland, Netherlands, Switzerland, And Rest Of Europe) -Industry Trends & Forecast To 2032

Overview of the Europe Gastrointestinal Endoscopy are:

Driver

• Rising Prevalence of Gastrointestinal Disorders

Restrain

• High Cost of Equipment and Procedures
Opportunity

• Growing Emphasis on Early Colorectal Cancer Detection

Market Players:

The key market players for Europe Gastrointestinal Endoscopy are listed below:

• Medtronic (Ireland)
• Stryker (U.S.)
• Johnson & Johnson Services, Inc. (U.S.)
• Boston Scientific Corporation (U.S.)
• Cook (U.S.)
• CONMED Corporation (U.S.)
• STERIS (U.S.)
• Henry Schein, Inc. (U.S.)
• CapsoVision, Inc. (U.S.)
• Teleflex Incorporated (U.S.)
• FUJIFILM Holdings Corporation (Japan)
• Olympus Corporation (Japan)
• Smith+Nephew (UK)
• Ambu A/S (Denmark)
• KLS Martin Group (Germany)
• Ovesco Endoscopy AG (Germany)
• Erbe Elektromedizin GmbH (Germany)

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 INTRODUCTION 93
1.1 OBJECTIVES OF THE STUDY 93
1.2 MARKET DEFINITION 93
1.3 OVERVIEW OF THE EUROPE GASTROINTESTINAL ENDOSCOPY MARKET 93
1.4 LIMITATIONS 95
1.5 MARKETS COVERED 95
2 MARKET SEGMENTATION 98
2.1 MARKETS COVERED 98
2.2 GEOGRAPHICAL SCOPE 99
2.3 YEARS CONSIDERED FOR THE STUDY 100
2.4 CURRENCY AND PRICING 100
2.5 DBMR TRIPOD DATA VALIDATION MODEL 101
2.6 MULTIVARIATE MODELLING 104
2.7 PRODUCT LIFELINE CURVE 105
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 106
2.9 DBMR MARKET POSITION GRID 107
2.10 VENDOR SHARE ANALYSIS 108
2.11 MARKET END USER COVERAGE GRID 109
2.12 SECONDARY SOURCES 110
2.13 ASSUMPTIONS 110
3 EXECUTIVE SUMMARY 111
4 PREMIUM INSIGHTS 116
4.1 PESTAL ANALYSIS 117
4.2 PORTERS FIVE FORCES ANALYSIS 118
4.3 INDUSTRY INSIGHTS 119
4.3.1 MICRO AND MACROECONOMIC FACTORS 119
4.3.2 PENETRATION AND GROWTH PROSPECT MAPPING 119
4.3.3 KEY PRICING STRATEGIES 119
4.3.4 COST ANALYSIS BREAKDOWN 119
4.3.5 TECHNOLOGY ROADMAP 119
4.3.6 OPPUTUNITY MAP ANALYSIS 120
4.3.7 PRICING ANALYSIS 120
4.3.8 COMPETITOR’S MODEL ANALYSIS 120
4.3.9 HEALTHCARE ECONOMY 120
4.3.9.1 HEALTHCARE EXPENDITURE 120
4.3.9.2 CAPITAL EXPENDITURE 120
4.3.9.3 CAPEX TRENDS 121
4.3.9.4 CAPEX ALLOCATION 121
4.3.9.5 FUNDING SOURCES 121
4.3.9.6 INDUSTRY BENCHMARKS 121
4.3.9.7 GDP RATIO IN OVERALL GDP 121
4.3.9.8 HEALTHCARE SYSTEM STRUCTURE 122
4.3.9.9 GOVERNMENT POLICIES 122
4.3.9.10 ECONOMIC DEVELOPMENT 122
4.4 CURRENT TARIFF RATE (S) IN TOP-5 COUNTRY MARKETS 123
4.4.1 OUTLOOK: LOCAL PRODUCTION V/S IMPORT RELIANCE 123
4.4.2 VENDOR SELECTION CRITERIA DYNAMICS 124
4.4.3 IMPACT ON SUPPLY CHAIN 124
4.4.3.1 RAW MATERIAL PROCUREMENT 125
4.4.3.2 MANUFACTURING AND PRODUCTION 125
4.4.3.3 LOGISTICS AND DISTRIBUTION 126
4.4.3.4 PRICE PITCHING AND POSITION OF MARKET 126
4.4.4 INDUSTRY PARTICIPANTS: PROACTIVE MOVES 127
4.4.4.1 SUPPLY CHAIN OPTIMIZATION 127
4.4.4.2 JOINT VENTURE ESTABLISHMENTS 128
4.4.5 IMPACT ON PRICES 129
4.4.6 REGULATORY INCLINATION 129
4.4.6.1 GEOPOLITICAL SITUATION 130
4.4.6.2 TRADE PARTNERSHIPS BETWEEN THE COUNTRIES 130
4.4.6.3 FREE TRADE AGREEMENTS 131
4.4.6.4 ALLIANCES ESTABLISHMENTS 131
4.4.6.5 STATUS ACCREDITATION (INCLUDING MFTN) 132
4.4.6.6 DOMESTIC COURSE OF CORRECTION 132
4.4.6.7 INCENTIVE SCHEMES TO BOOST PRODUCTION OUTPUTS 133
4.4.6.8 ESTABLISHMENT OF SPECIAL ECONOMIC ZONES/INDUSTRIAL PARKS 134
4.4.7 PRICE INDEX 134
4.5 INNOVATION TRACKER AND STRATEGIC ANALYSIS 135
4.6 SUPPLY CHAIN ECOSYSTEM 137
4.7 COMPANY EVALUATION QUADRANT 138
5 REGULATORY COMPLIANCE 139
5.1 REGULATORY AUTHORITIES 139
5.2 REGULATORY CLASSIFICATIONS 140
5.3 REGULATORY SUBMISSIONS 141
5.4 INTERNATIONAL HARMONIZATION 141
5.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS 141
5.6 REGULATORY CHALLENGES AND STRATEGIES 141
6 MARKET OVERVIEW 142
6.1 DRIVERS 144
6.1.1 RISING PREVALENCE OF GASTROINTESTINAL DISORDERS 144
6.1.2 AGING POPULATION DRIVING INCREASED DEMAND FOR GI ENDOSCOPY 145
6.1.3 TECHNOLOGICAL ADVANCEMENTS ENHANCING GI ENDOSCOPY PROCEDURES 146
6.1.4 RISING AWARENESS AND EXPANDED SCREENING PROGRAMS FOR GASTROINTESTINAL ENDOSCOPY 147
6.2 RESTRAINTS 148
6.2.1 HIGH COST OF EQUIPMENT AND PROCEDURES 148
6.2.2 RISK OF PROCEDURE-RELATED COMPLICATIONS 149
6.3 OPPORTUNITIES 150
6.3.1 GROWING EMPHASIS ON EARLY COLORECTAL CANCER DETECTION 150
6.3.2 GROWING ADOPTION OF HOME-BASED AND CAPSULE ENDOSCOPY SOLUTIONS 151
6.3.3 INCREASING PREVALENCE AND ADVANCEMENTS IN PERSONALIZED THERAPEUTIC ENDOSCOPY 152
6.4 CHALLENGES 153
6.4.1 LIMITED ACCESS TO GI ENDOSCOPY IN RURAL AREAS 153
6.4.2 COMPLEXITIES IN ENDOSCOPE REPROCESSING AND STERILIZATION PROCESSES 154
7 EUROPE GASTROINTESTINAL ENDOSCOPY MARKET, BY PRODUCT 155
7.1 OVERVIEW 156
7.2 GASTROINTESTINAL ENDOSCOPES & SYSTEMS 159
7.2.1 ENDOSCOPES 161
7.2.1.1 COLONOSCOPES 162
7.2.1.2 GASTROSCOPES 162
7.2.1.3 DUODENOSCOPES 162
7.2.1.4 ENTEROSCOPES 162
7.2.1.5 SIGMOIDOSCOPES 162
7.2.1.6 RESECTOSCOPES 162
7.2.2 FLEXIBLE 163
7.2.3 RIGID 163
7.2.4 SEMI RIGID 163
7.2.4.1 VIDEO 164
7.2.4.2 FIBRE 164
7.2.4.3 ULTRASONIC 164
7.2.5 VISUALIZATION SYSTEMS 165
7.2.5.1 FLUORESCENCE IMAGING SYSTEMS 165
7.2.5.1.1 NIR LIGHT FLUORESCENCE IMAGING SYSTEM 166
7.2.5.1.2 WHITE LIGHT FLUORESCENCE IMAGING SYSTEM 166
7.2.5.1.3 UV LIGHT FLUORESCENCE IMAGING SYSTEMS 166
7.2.5.1.4 CONFOCAL LASER ENDOSCOPY IMAGING SYSTEMS 166
7.2.5.1.5 PROBE-BASED CLE (PCLE) 167
7.2.5.1.6 BUILT-IN DEVICE CLE (ECLE) 167
7.2.5.2 HIGH DEFINITION (HD) VISUALIZATION SYSTEMS 168
7.2.5.2.1 2D SYSTEMS 168
7.2.5.2.2 3D SYSTEMS 168
7.2.5.3 STANDARD DEFINITION (SD) VISUALIZATION SYSTEMS 169
7.2.5.3.1 ENDOSCOPIC ULTRASONOGRAPHY SYSTEMS 169
7.2.5.3.2 CAPSULE ENDOSCOPES 169
7.2.5.3.3 ULTRASOUND DEVICE 169
7.3 GASTROINTESTINAL ENDOTHERAPY 170
7.3.1 ERCP DEVICES 172
7.3.2 BIOPSY DEVICE 172
7.3.3 STENTING AND DILATION DEVICE 172
7.3.4 HOMEOSTASIS DEVICES 172
7.3.4.1 LIGATION DEVICES 173
7.3.4.2 PROBES 173
7.3.4.3 SCLEROTHERAPY NEEDLES 173
7.3.5 RETRIEVAL DEVICES 174
7.3.6 CAMERA HEAD 174
7.3.7 ANTI-REFLUX DEVICES 174
7.3.7.1 TRANSORAL INCISIONLESS FUNDOPLICATION (TIF) DEVICES 174
7.3.7.2 TRANSESOPHAGEAL RADIOFREQUENCY (RF) ANTI-REFLUX DEVICES 174
7.3.8 OTHERS 175
8 EUROPE GASTROINTESTINAL ENDOSCOPY MARKET, BY PROCEDURE TYPE 176
8.1 OVERVIEW 177
8.2 COLONOSCOPY 180
8.3 GASTROSCOPY 181
8.4 DUODENOSCOPY 181
8.5 ENTEROSCOPY 182
8.6 SIGMOIDOSCOPY 182
8.7 OTHERS 183
9 EUROPE GASTROINTESTINAL ENDOSCOPY MARKET, BY USABILITY 184
9.1 OVERVIEW 185
9.2 REUSABLE 188
9.3 DISPOSABLE/ SINGLE USE 189
10 EUROPE GASTROINTESTINAL ENDOSCOPY MARKET, BY APPLICATION 190
10.1 OVERVIEW 191
10.2 TREATMENT 194
10.3 DIAGNOSIS 195
11 EUROPE GASTROINTESTINAL ENDOSCOPY MARKET, BY END USER 196
11.1 OVERVIEW 197
11.2 HOSPITALS 201
11.3 AMBULATORY SURGICAL CENTERS 202
11.4 SPECIALTY CLINICS 203
11.5 LABORATORIES 203
11.6 OTHERS 204
12 EUROPE GASTROINTESTINAL ENDOSCOPY MARKET, BY DISTRIBUTION CHANNEL 205
12.1 OVERVIEW 206
12.2 DIRECT TENDER 209
12.3 RETAIL SALES 210
12.4 OTHERS 210
13 EUROPE GASTROINTESTINAL ENDOSCOPY MARKET, BY REGION 211
13.1 EUROPE 213
13.1.1 GERMANY 228
13.1.2 FRANCE 241
13.1.3 U.K. 255
13.1.4 ITALY 268
13.1.5 SPAIN 280
13.1.6 RUSSIA 292
13.1.7 SWITZERLAND 304
13.1.8 NETHERLANDS 316
13.1.9 POLAND 328
13.1.10 TURKEY 340
13.1.11 REST OF EUROPE 353
14 EUROPE GASTROINTESTINAL ENDOSCOPY MARKET: COMPANY LANDSCAPE 354
14.1 COMPANY SHARE ANALYSIS: EUROPE 354
15 SWOT ANALYSIS 355
16 COMPANY PROFILES 356
16.1 OLYMPUS CORPORATION 356
16.1.1 COMPANY SNAPSHOT 356
16.1.2 REVENUE ANALYSIS 356
16.1.3 COMPANY SHARE ANALYSIS 357
16.1.4 PRODUCT PORTFOLIO 357
16.1.5 RECENT DEVELOPMENT/NEWS 359
16.2 FUJIFILM HOLDINGS CORPORATION 360
16.2.1 COMPANY SNAPSHOT 360
16.2.2 REVENUE ANALYSIS 360
16.2.3 COMPANY SHARE ANALYSIS 361
16.2.4 PRODUCT PORTFOLIO 361
16.2.5 RECENT DEVELOPMENTS/NEWS 362
16.3 MEDTRONIC 364
16.3.1 COMPANY SNAPSHOT 364
16.3.2 REVENUE ANALYSIS 364
16.3.3 COMPANY SHARE ANALYSIS 365
16.3.4 PRODUCT PORTFOLIO 365
16.3.5 RECENT DEVELOPMENTS/NEWS 367
16.4 JOHNSON & JOHNSON SERVICES, INC. 368
16.4.1 COMPANY SNAPSHOT 368
16.4.2 REVENUE ANALYSIS 368
16.4.3 COMPANY SHARE ANALYSIS 369
16.4.4 PRODUCT PORTFOLIO 369
16.4.5 RECENT DEVELOPMENTS 369
16.5 STRYKER 370
16.5.1 COMPANY SNAPSHOT 370
16.5.2 REVENUE ANALYSIS 370
16.5.3 COMPANY SHARE ANALYSIS 371
16.5.4 PRODUCT PORTFOLIO 371
16.5.5 RECENT DEVELOPMENT 372
16.6 AMBU AS 373
16.6.1 COMPANY SNAPSHOT 373
16.6.2 REVENUE ANALYSIS 373
16.6.3 PRODUCT PORTFOLIO 374
16.6.4 RECENT DEVELOPMENTS/NEWS 375
16.7 ANX ROBOTICS 376
16.7.1 COMPANY SNAPSHOT 376
16.7.2 PRODUCT PORTFOLIO 376
16.7.3 RECENT DEVELOPMENTS/NEWS 377
16.8 BOSTON SCIENTIFIC CORPORATION 378
16.8.1 COMPANY SNAPSHOT 378
16.8.2 REVENUE ANALYSIS 378
16.8.3 PRODUCT PORTFOLIO 379
16.8.4 RECENT DEVELOPMENT 381
16.9 CAPSOVISION, INC. 382
16.9.1 COMPANY SNAPSHOT 382
16.9.2 PRODUCT PORTFOLIO 382
16.9.3 RECENT DEVELOPMENTS/NEWS 383
16.10 CONMED CORPORATION 384
16.10.1 COMPANY SNAPSHOT 384
16.10.2 PRODUCT PORTFOLIO 385
16.10.3 RECENT DEVELOPMENTS 388
16.11 COOK 389
16.11.1 COMPANY SNAPSHOT 389
16.11.2 PRODUCT PORTFOLIO 389
16.11.3 RECENT DEVELOPMENT/NEWS 391
16.12 DAICHUAN MEDICAL 392
16.12.1 COMPANY SNAPSHOT 392
16.12.2 PRODUCT PORTFOLIO 392
16.12.3 RECENT DEVELOPMENT 392
16.13 ERBE ELEKTROMEDIZIN GMBH 393
16.13.1 COMPANY SNAPSHOT 393
16.13.2 PRODUCT PORTFOLIO 393
16.13.3 RECENT DEVELOPMENT 395
16.14 GONGJIANG ENDOSCOPY INSTRUMENTS CO., LTD 396
16.14.1 COMPANY SNAPSHOT 396
16.14.2 PRODUCT PORTFOLIO 396
16.14.3 RECENT DEVELOPMENT 396
16.15 HENRY SCHEIN, INC. 397
16.15.1 COMPANY SNAPSHOT 397
16.15.2 REVENUE ANALYSIS 397
16.15.3 PRODUCT PORTFOLIO 398
16.15.4 RECENT DEVELOPMENT 398
16.16 HOYA CORPORATION. 399
16.16.1 COMPANY SNAPSHOT 399
16.16.2 REVENUE ANALYSIS 399
16.16.3 PRODUCT PORTFOLIO 400
16.16.4 RECENT DEVELOPMENT 402
16.17 INTROMEDIC 403
16.17.1 COMPANY SNAPSHOT 403
16.17.2 PRODUCT PORTFOLIO 403
16.17.3 RECENT DEVELOPMENT 403
16.18 JIANGSU VEDKANG MEDICAL SCIENCE AND TECHNOLOGY CO., LTD 404
16.18.1 COMPANY SNAPSHOT 404
16.18.2 PRODUCT PORTFOLIO 404
16.18.3 RECENT DEVELOPMENT 406
16.19 JINSHAN SCIENCE & TECHNOLOGY 407
16.19.1 COMPANY SNAPSHOT 407
16.19.2 PRODUCT PORTFOLIO 407
16.19.3 RECENT DEVELOPMENT/NEWS 409
16.20 KLS MARTIN GROUP 410
16.20.1 COMPANY SNAPSHOT 410
16.20.2 PRODUCT PORTFOLIO 410
16.20.3 RECENT DEVELOPMENT 412
16.21 LABORIE 413
16.21.1 COMPANY SNAPSHOT 413
16.21.2 PRODUCT PORTFOLIO 413
16.21.3 RECENT DEVELOPMENT 416
16.22 MECANMEDICAL 417
16.22.1 COMPANY SNAPSHOT 417
16.22.2 PRODUCT PORTFOLIO 417
16.22.3 RECENT DEVELOPMENT 418
16.23 MICRO-TECH ENDOSCOPY 419
16.23.1 COMPANY SNAPSHOT 419
16.23.2 PRODUCT PORTFOLIO 419
16.23.3 RECENT DEVELOPMENT 421
16.24 MITRA INDUSTRIES PVT. LTD. 422
16.24.1 COMPANY SNAPSHOT 422
16.24.2 PRODUCT PORTFOLIO 422
16.24.3 RECENT DEVELOPMENT 423
16.25 OVESCO ENDOSCOPY AG 424
16.25.1 COMPANY SNAPSHOT 424
16.25.2 PRODUCT PORTFOLIO 424
16.25.3 RECENT DEVELOPMENT 426
16.26 SHAILI ENDOSCOPY 428
16.26.1 COMPANY SNAPSHOT 428
16.26.2 PRODUCT PORTFOLIO 428
16.26.3 RECENT DEVELOPMENT 430
16.27 SMITH+NEPHEW 431
16.27.1 COMPANY SNAPSHOT 431
16.27.2 REVENUE ANALYSIS 431
16.27.3 PRODUCT PORTFOLIO 432
16.27.4 RECENT DEVELOPMENT 432
16.28 SONOSCAPE MEDICAL CORP. 433
16.28.1 COMPANY SNAPSHOT 433
16.28.2 REVENUE ANALYSIS 434
16.28.3 PRODUCT PORTFOLIO 434
16.28.4 RECENT DEVELOPMENT/NEWS 436
16.29 STERIS 437
16.29.1 COMPANY SNAPSHOT 437
16.29.2 REVENUE ANALYSIS 437
16.29.3 PRODUCT PORTFOLIO 438
16.29.4 RECENT DEVELOPMENT 439
16.30 TELEFLEX INCORPORATED. 440
16.30.1 COMPANY SNAPSHOT 440
16.30.2 REVENUE ANALYSIS 440
16.30.3 PRODUCT PORTFOLIO 441
16.30.4 RECENT DEVELOPMENT 442
17 QUESTIONNAIRE 443